Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexpramipexole in Hypereosinophilic Syndrome
NCT02101138Phase 2Unknown
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexpramipexole in hypereosinophilic syndrome (HES), sponsored by National Institute of Allergy and Infectious Diseases. Status: unknown.
02
Drugs
dexpramipexole
03
Conditions
hypereosinophilic syndrome (HES)
Beyond the preview
Go deeper on NCT02101138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02101138.